Hedge Fund

Incision Capital Management LP — 13F Portfolio

13F Institutional Investment Manager (likely private fund adviser; specific registration status should be confirmed via SEC IAPD/EDGAR records) Institutional CIK: 0002049997
13F Score ?
3Y · Top 10 · Mgr Wt
13F Score ?
7Y · Top 10 · Mgr Wt
S&P 500 ?
80
Benchmark
$91M
AUM
+4.86%
2026 Q1
+0.00%
1-Year Return
+100.00%
Top 10 Concentration
+28.19%
Turnover
-17.81%
AUM Change
Since 2025
First Filing
4
# of Holdings

Fund Overview

13F Filed: 2026-05-15

As of 2026 Q1, Incision Capital Management Lp manages $91M in reported 13F assets , holds 4 positions with +100.00% top-10 concentration . Filing 13F reports since 2025. View full holdings list →

About

Investment Strategy

Analytics Summary

Risk Profile

Official 13F Filings — SEC EDGAR Key personnel and Fund Overview may contain mistakes

Activity Summary — 2026 Q1

Q1 2026 13F Filed: May 15, 2026

Top Buys

% $
Stock % Impact
+18.18%
+8.62%
+1.39%

Top Sells

% $
Stock % Impact
Sold All 😨 Was: 21.01% -25.57%
Sold All 😨 Was: 16.88% -20.54%
-3.69%
PUT Option
Sold All 😨 Was: 0.05%
-0.06%

Top Holdings

2026 Q1 Top 6 mgr. wt. · 2026 Q1+4.86%
Stock %
32.07%
28.33%
21.42%
18.18%
View All Holdings

Activity Summary

Latest
Market Value $91M
AUM Change -17.81%
New Positions 1
Increased Positions 2
Closed Positions 3
Top 10 Concentration +100.00%
Portfolio Turnover +28.19%
Alt Turnover +39.03%

Sector Allocation Trends

Quarterly History
Free View: Last 10 Quarters. Subscribe to see full history

Holdings Analysis

Size: % of Portfolio Color: Last Full-Quarter Return No data
Free: 10 quarters

Positions Dynamics

Visualizing Top 20 holdings weight history over the last 10 quarters.

Portfolio Analytics — Latest

Incision Capital Management LP risk dashboard covering volatility, beta, value-at-risk, drawdowns, concentration, factor tilts, benchmark comparison, and stress testing for the latest disclosed portfolio.

Risk access
Building institutional risk profile...
Guru Intelligence Hub Pro
Real-time Analytics
High-Conviction Alpha
AAPL 92.4
NVDA 88.1
MSFT 74.3
Strategy Guardian
Style Drift 0.12
Sector Rotation 0.38

Tracking institutional benchmark deviation

Scenario Lab
2008 GFC -32.4%
Covid-19 -18.1%
2022 Bear -24.7%
Unlock the full Guru Intelligence Hub
Real conviction scores for every holding  ·  Strategy Guardian alerts  ·  Live Scenario Lab stress tests
Upgrade to Pro

Best Strategy vs. Benchmarks

AI Backtest: Auto-Optimizing...
Loading AI Backtest...
Don't be Fooled by Randomness
Access Alpha, Capture Ratios, and Batting Average calibrated for this specific strategy.
UPGRADE NOW
Nassim Taleb — author of Fooled by Randomness
Returns
--
Latest Quarter
--
1-Year Return
--
Ann. Return
Risk
--
Std Deviation
--
Max Drawdown
--
Beta vs SPY
Quality
--
Sharpe
--
Sortino
--
Win Rate
--
Payoff Ratio
Edge Metrics Last 10 quarters only
--
Alpha annualized
--
Up Capture
--
Down Capture

Strategy Backtester: Incision Capital Management LP

Replicate top holdings performance • Compare vs benchmarks • Optimize N

Find the best N! Test multiple portfolio sizes at once to discover the optimal configuration.

Risk insights! Identify periods when the fund lagged the benchmark – critical for timing entries.

⏱ Run Backtest

Liquid Glass Edition

0
Backtests Run
+127%
Avg. Return

👆 Click the button to launch tickers!

Don't Be Fooled by Randomness
Proven alpha spans cycles, not just 24 months. Unlock full history since 1999.
PRO ACCESS
Free Demo
Try the Backtester on Real Funds
Run full-history backtests on a curated 2-3 funds. See signal quality, drawdowns, and cycle behavior before you decide.
Underperformance Analysis — Top 10 Holdings vs SPY

Backtesting Incision Capital Management LP's top 10 holdings against SPY identified 1 underperformance period. Worst drawdown: 2026-03 – 2026-04 (-6.1% vs SPY, 2 quarters). Currently underperforming.

Avg. lag: -6.1% vs SPY Avg. duration: 2.0 quarters
Backtest Snapshot — Top 10 Holdings (Mn-Weighted)

The ticker-level breakdown shows how each of Incision Capital Management LP's top holdings contributed to portfolio returns quarter by quarter. Strongest recent contributors inside the last 5 years of the quarterly Top 10 backtest window: CVE (2025 Q4 – 2025 Q4, +6.9 pts), TECK (2025 Q4 – 2025 Q4, +2.7 pts) .

Strategy ann.: 16.6% SPY ann.: 27.0% Period: 2026–2026
Best Recent Contributors — Last 5Y
All 2 recent top contributors beat SPY, which means this fund's strongest recent return drivers also outperformed the index over the same window.
2025 Q4 – 2025 Q4 • 1Q in Top 10 Beat SPY
CVE
+41%
SPY
+9%
Contrib
+6.9%
2025 Q4 – 2025 Q4 • 1Q in Top 10 Beat SPY
TECK
+13%
SPY
+9%
Contrib
+2.7%
Stock return (green = beat SPY)   Stock return (red = lagged SPY)   SPY same period   Cumulative contribution during the last 5 years of the quarterly Mn-weighted Top 10 strategy

Frequently Asked Questions

What does Incision Capital Management Lp invest in?
Incision Capital Management LP does not publish a detailed, plain-language strategy description in widely accessible channels. Its practical mandate therefore has to be inferred from its structure as a private partnership and, more concretely, from the pattern of securities disclosed in its 13F reports. From a holdings-based standpoint, characterizing the strategy begins with several observable dimensions: - **Breadth and concentration:** The number of 13F-reportable positions and the share of disclosed value accounted for by the top names indicate whether the firm runs a concentrated, high-conviction book or a more diversified portfolio. - **Sector and thematic tilts:** The distribution of holdings across sectors (technology, health care, financials, industrials, consumer, etc.) and persistent overweights or underweights versus broad benchmarks reveal whether the portfolio is organized around secular growth themes, value recovery, cyclicals, defensives, or more idiosyncratic ideas. - **Implementation mix:** The balance between single-name equities and pooled vehicles such as ETFs clarifies the degree of direct stock selection versus reliance on index or factor proxies. - **Turnover pattern:** The scale of quarter-to-quarter changes in holdings and position sizes distinguishes a long-horizon, buy-and-hold orientation from more tactical, trading- or catalyst-driven approaches. Absent a published mandate, these empirical features of the 13F record become the primary evidence to classify whether Incision Capital Management LP behaves more like a concentrated fundamental stock-picker, a diversified equity allocator with active tilts, or a more opportunistic, event- or factor-driven manager. Using a Portfolio Simulator or Backtesting Service, the sequence of quarterly holdings can be transformed into a time series of hypothetical portfolio values, normalized to a user-defined notional. This process yields an approximate **Historical Track Record** for the 13F-visible long U.S. equity sleeve. Analysts can then compare the reconstructed capital trajectory to relevant benchmarks (such as broad U.S. equity indices or style-specific indices), identify periods in which observed sector or factor tilts contributed positively or negatively, and assess the consistency of the inferred style across different market regimes. Because shorts, leverage, and non-U.S. positions are not disclosed on Form 13F, this reconstructed history should be interpreted strictly as the long-side U.S. equity behavior of the strategy, not as a complete representation of the partnership’s overall positioning.
What is Incision Capital Management Lp's AUM?
Incision Capital Management Lp reported $91M in 13F assets as of 2026 Q1. Note: 13F AUM reflects only long equity positions reported to the SEC and may differ from total assets under management.
How concentrated is Incision Capital Management Lp's portfolio?
Incision Capital Management Lp holds 4 disclosed positions. The top 10 holdings represent +100.00% of the reported portfolio, indicating a highly concentrated investment approach.
How to track Incision Capital Management Lp 13F filings?
Track Incision Capital Management Lp's quarterly filings on SEC EDGAR or on this page — data is updated within days of each filing deadline. Subscribe to 13Foresight for position-change alerts.

Disclaimer: 13Foresight is not a registered investment adviser, broker-dealer, or financial planner. All information on this site is provided solely for informational and educational purposes and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Portfolio backtests shown on this page are hypothetical and simulated — they do not represent actual trading results and were constructed with the benefit of hindsight. Actual results would differ materially. 13F filings disclose only long equity positions valued above $10,000, submitted up to 45 days after quarter-end; they do not capture short positions, options, bonds, cash, private investments, or non-U.S. securities. A fund's backtest performance may not reflect its actual returns, as managers frequently generate alpha through strategies not visible in 13F data. Past performance is not indicative of future results. All data sourced from public SEC EDGAR filings. Use at your own risk. Full Terms of Use.

Full history →